Ani pharmaceuticals announces the launch of ani global source, its contract development and manufacturing business

Ani pharmaceuticals, inc. announced the launch of its new cdmo brand, ani global source. this action follows the integration of wellspring pharma services, acquired one year ago, and demonstrates the progress the company has made since the acquisition. ani global source is a specialty cdmo supporting late stage development and commercial manufacture of pharmaceutical products including tablets & capsules, liquid solutions, suspensions, topical liquids, creams and gels with unique expertise in hormones, potent compounds, and controlled substances. ani global source will continue to leverage its robust infrastructure including over 300 employees and 270,000 square feet of manufacturing and packaging facilities across multiple sites.
ANIP Ratings Summary
ANIP Quant Ranking